Delivery Order SPE2DB22D3004-SPE2DB24FPW08
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp (a subsidiary of AmerisourceBergen Corporation) to provide Eliquis 5 mg tablets. The $8,770.83 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense, through multiple...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Eliquis 5 mg tablets. The total ceiling value of this contract is $22,619.00 with a period of performance through April 9, 2024. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) issued by DLA to AmerisourceBergen Drug Corp as a single award vehicle to supply...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablets. The $23,922.48 contract has a performance period through March 27, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract with DLA to provide a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency (DLA) awarded a $12,763.52 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp to provide pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The IDC does not...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $25,347.47 award is for the supply of Eliquis 5 mg tablets, a brand name pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Eliquis 5 mg tablets. The contract has a potential value of $5,872.82 and a completion date of March 7, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. AmerisourceBergen Drug Corp also holds an indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $12,049.99 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 26, 2025. The award was issued on August 25, 2025, with no set-aside designation applied. This delivery order is a child contract executed under AmerisourceBergen's...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $101,266.28 firm fixed price delivery order is for the supply of Eliquis 5 mg tablets. The contract has a completion date of May 17, 2022 and was awarded on May 16, 2022. Amerisourcebergen Drug Corporation, through its Corporate Office division, has...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablets. The $7,968.77 contract has a completion date of February 13, 2024 and was awarded on February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is not associated with any set-aside designations or larger contract vehicles. The company provides a wide...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract, SPE2DX15D3007|SPE2DX24F9K4Z, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Eliquis 5 mg tablets. The $4,269.89 contract has a performance period through March 15, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous delivery order...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPW08Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 5 mg Eliquis tablets. The $20,269.82 contract does not have a set-aside designation and has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense, under multiple indefinite delivery contracts. This specific delivery order is a discrete award associated with a larger $999,999,999.00 indefinite delivery contract that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceuticals and medical supplies to military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.3k | 4/3/24 |